Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DLBS3233

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Plant Extracts

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The Effect of Metformin and Cinnamon on Serum Anti-Mullerian Hormone in Women Having PCOS: A Double-Blind, Randomized, Controlled Trial
Background: Polycystic ovary syndrome (PCOS) is known to be associated with insulin resistance and anti-Mullerian hormone (AMH… Expand
  • figure 2
  • figure 1
  • table 1
  • table 3
  • table 2
2017
2017
Simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology
Simultaneous micronization and purification of DLBS3233 bioactive fraction, a combination of two Indonesian herbals Lagerstroemia… Expand
2016
2016
Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa
Background The aim of this paper is to evaluate the efficacy and safety of DLBS3233, a novel bioactive fraction derived from… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
2016
2016
DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa, in type-2 diabetes mellitus patients inadequately controlled by metformin and other oral antidiabetic agents
Abstract Background DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa, has preclinically… Expand
  • table 1
  • table 2
  • table 4
  • table 3
  • table 5
2016
2016
CLINICAL EXPERIENCE WITH DLBS3233, A COMBINATION OF CINNAMOMMUM BURMANNII AND LAGERSTROEMIA SPECIOSA, FOR POLYCYSTIC OVARY SYNDROME TREATMENT
ABSTRACT Objective: DLBS3233, a new insulin sensitizing agent for Type 2 diabetes, is a combination-bioactive-fraction derived… Expand
  • table 1
  • table 2
  • table 3
2016
2016
MOLECULAR ANALYSIS OF GENE EXPRESSION RELATED TO THE EFFECTS OF DLBS3233 TREATMENT IN DIFFERENTIATION OF 3T3-L1 PRE-ADIPOCYTE
Objective: DLBS3233 is a standardized extract combination containing Lagerstroemia speciosa and Cinnamomum burmannii . The effect… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
2012
2012
DLBS3233 extract, a novel insulin sensitizer with negligible risk of hypoglycemia: A phase-I study
DLBS3233 is a standardized extract combination of two Indonesian herbals (Lagerstroemia speciosa L. and Cinnamomum burmanii L… Expand
2011
2011
Glucose-lowering effect of DLBS3233 is mediated through phosphorylation of tyrosine and upregulation of PPARγ and GLUT4 expression
Background: DLBS3233 is a standardized extract combination containing Lagerstroemia speciosa and Cinnamomum burmannii. The effect… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE